Multiple%20Myeloma
Showing 26 - 50 of >10,000
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)
Not yet recruiting
- Multiple Myeloma
- +3 more
- Auricular Acupuncture
- (no location specified)
Mar 7, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory
Not yet recruiting
- Multiple Myeloma
-
Durham, North CarolinaDuke University Medical Center
Aug 8, 2023
Multiple Myeloma Trial (Patient Reported Outcomes)
Not yet recruiting
- Multiple Myeloma
- Patient Reported Outcomes
- (no location specified)
Apr 24, 2023
Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Frailty
- (no location specified)
Oct 30, 2023
Optical Genome Mapping in Characterization of Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Bone Marrow samples collection
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Mar 15, 2023
Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)
Not yet recruiting
- Relapsed or Refractory Multiple Myeloma
- Forimtamig
- +2 more
- (no location specified)
Sep 20, 2023
Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)
Recruiting
- Multiple Myeloma in Remission
- MM-specific universal CAR T cells
-
Shenzhen, Guangdong, China
- +1 more
Aug 23, 2023
Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 2001
-
Benowa, Queensland, AustraliaPindara Private Hospital
May 18, 2023
Determine the Optimal Initial Therapy for Multiple Myeloma
Recruiting
- Multiple Myeloma
- Non-Interventional Study
-
Scottsdale, Arizona
- +3 more
Nov 22, 2023
Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)
Not yet recruiting
- Refractory Multiple Myeloma
- Relapsed Multiple Myeloma
- Iberdomide
- +6 more
-
Miami, FloridaUniversity of Miami
May 31, 2023
Real-World Mapping Antithrombotic Regimens in MM Patients on
Not yet recruiting
- Multiple Myeloma
- Diagnosis
- (no location specified)
Aug 31, 2023
Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)
Recruiting
- Relapse/Refractory Multiple Myeloma
- DeepTag-GPRC5D Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023
Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)
Not yet recruiting
- Relapsed and Refractory Multiple Myeloma
- Mezigdomide
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 15, 2023
Multiple Myeloma Trial in Saint Louis (Care transition, No care transition)
Not yet recruiting
- Multiple Myeloma
- Care transition
- No care transition
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
-
Miami, FloridaUniversity of Miami
Oct 20, 2023
Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)
Recruiting
- Multiple Myeloma
- APRIL-BAFF-Bicephali CAR-T cells
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 14, 2023
Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)
Not yet recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023
Real-world Usage of HyQvia in Multiple Myeloma Secondary
Not yet recruiting
- Multiple Myeloma
- Secondary Immunodeficiency (SID)
- No Intervention
- (no location specified)
May 19, 2023
Health Technology Intervention on Patient Activation in Multiple
Not yet recruiting
- Multiple Myeloma in Relapse
- +3 more
- (no location specified)
Jan 9, 2023
Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Myeloma-Associated Amyloidosis
- Selinexor
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 6, 2023
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023